Literature DB >> 32255547

Incidence, progression and risk factors of age-related cataract in Malays: The Singapore Malay Eye Study.

Ava Grace Tan1, Yih Chung Tham2, Miao Li Chee2, Paul Mitchell1, Robert G Cumming3, Charumathi Sabanayagam2,4,5, Tien Y Wong2,4,5, Jie Jin Wang1,6, Ching-Yu Cheng2,4,5.   

Abstract

IMPORTANCE: Long-term data on age-related cataract, a leading cause of blindness and visual impairment, is scarce in Asian populations.
BACKGROUND: We report the 6-year incidence and progression of age-related cataract and associated risk factors in Malay adults living in Singapore.
DESIGN: Population-based cohort study. PARTICIPANTS: A total of 3280 Malays aged 40+ years participated in baseline examinations of the Singapore Malay Eye Study (2004-2006). Six years later, 1901 (72.1% of eligible) baseline participants were re-examined.
METHODS: Cataract was assessed using lens photos, taken during eye examinations, following the Wisconsin Cataract Grading System. MAIN OUTCOMES AND MEASURES: Incidence and progression of cortical, nuclear and posterior subcapsular (PSC) cataract. Poisson regression models and generalized estimating equations models (with Poisson link) were used to assess factors associated with cataract incidence and progression, respectively, adjusting for age, sex and other risk factors.
RESULTS: Age-adjusted 6-year incidence of cortical, nuclear and PSC cataract was 14.1%, 13.6% and 8.7%, respectively, and was strongly age-related (P for trend <.001 for all types). Diabetes (relative risk [RR], 1.97; 95% confidence intervals [CI], 1.46-2.67) was associated with incident cortical cataract, hypertension was associated with PSC cataract incidence (RR, 2.09; 95% CI, 1.22-3.61), after multivariable adjustment. Progression occurred in 20.4%, 5.9% and 40.6% of baseline cortical, nuclear and PSC cataract cases, respectively. CONCLUSIONS AND RELEVANCE: Similar to other elderly populations, incidence and progression of cataract were common in this Malay population. Diabetes and hypertension were important modifiable risk factors for cataract, highlighting the importance of systemic health on eye disease.
© 2020 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  cataract; epidemiology; incidence; risk factor

Year:  2020        PMID: 32255547     DOI: 10.1111/ceo.13757

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  4 in total

1.  The association between cataract and sleep apnea: a nationwide population-based cohort study.

Authors:  Pei-Kang Liu; Yo-Chen Chang; Nan-Kai Wang; Joseph Ryu; Rong-Kung Tsai; Shiuh-Liang Hsu; Jen-Yu Hung; Chung-Yao Hsu; Ming-Hong Tai; Ming-Ju Tsai
Journal:  J Clin Sleep Med       Date:  2022-03-01       Impact factor: 4.062

2.  Metabolic Syndrome Is Associated with Cataract in a Large Taiwanese Population Study.

Authors:  Jung-Hsiu Chang; I-Hua Chen; Jiun-Hung Geng; Pei-Yu Wu; Jiun-Chi Huang; Szu-Chia Chen
Journal:  Nutrients       Date:  2022-04-19       Impact factor: 6.706

3.  Environmental effects of stratospheric ozone depletion, UV radiation, and interactions with climate change: UNEP Environmental Effects Assessment Panel, Update 2021.

Authors:  P W Barnes; T M Robson; P J Neale; C E Williamson; R G Zepp; S Madronich; S R Wilson; A L Andrady; A M Heikkilä; G H Bernhard; A F Bais; R E Neale; J F Bornman; M A K Jansen; A R Klekociuk; J Martinez-Abaigar; S A Robinson; Q-W Wang; A T Banaszak; D-P Häder; S Hylander; K C Rose; S-Å Wängberg; B Foereid; W-C Hou; R Ossola; N D Paul; J E Ukpebor; M P S Andersen; J Longstreth; T Schikowski; K R Solomon; B Sulzberger; L S Bruckman; K K Pandey; C C White; L Zhu; M Zhu; P J Aucamp; J B Liley; R L McKenzie; M Berwick; S N Byrne; L M Hollestein; R M Lucas; C M Olsen; L E Rhodes; S Yazar; A R Young
Journal:  Photochem Photobiol Sci       Date:  2022-02-21       Impact factor: 4.328

4.  Metformin alleviates oxidative stress-induced senescence of human lens epithelial cells via AMPK activation and autophagic flux restoration.

Authors:  Mengmeng Chen; Chunmei Zhang; Nan Zhou; Xu Wang; Dongmei Su; Yanhua Qi
Journal:  J Cell Mol Med       Date:  2021-07-23       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.